IMA calls for One drug – One company – One price

IMA calls for One drug - One company - One price

Uniformity of pricing still an issue that is left unaddressed

New Delhi, June1, 2017: In a bid to question the decision that urges doctors to prescribe generic and cheaper drugs, the IMA has called for a ‘One drug – One company – One price’ policy. This call comes as part of the month-long intensive campaign being undertaken by the Association as a clarion call against the issues faced by the medical fraternity today. The campaign will lead up to the Dilli Chalo movement to be organized on 6th June 2017.

Uniformity in pricing of medicines in India still remains a distant dream. The same company selling the same drug under different brand names and at different prices is even more inexplicable. Concerns have already been raised about the fact that a poor country like India has a weak drug price control mechanism.

Speaking about this, Padma Shri Awardee Dr K K Aggarwal, National President Indian Medical Association (IMA) and President Heart Care Foundation of India (HCFI) and Dr RN Tandon – Honorary Secretary General IMA in a joint statement, said, “The government allows the same salt to be sold by the same company at three difference prices as generic-generic, generic-trade or generic-branch. There is a need to adopt a ‘one drug – one company – one price’ policy. It is not reasonable for the government to grant a license to companies to sell drugs at different rates and then force doctors to choose only the cheaper drugs. It’s like giving licenses to open five star hotels, but simultaneously issuing an advisory to the public to not to go these hotels.”


The IMA feels that medicines cannot be up for free pricing and the decision to buy them is not determined by the consumer, but by doctors and at times the chemists.

Adding further, Dr Aggarwal said, “The need to buy medicines is immediate and involuntary, unlike other items. It is not fair for companies to increase prices to further increase their profit margins while putting the health of many people at stake. Therefore, it is important for the government to have a control over the pricing of drugs.”

The Dilli Chalo march will be joined by over a lakh doctors in the country, both digitally and physically, and followed by deliberations on issues ailing the medical profession, one of them being the drug pricing policy. The IMA is also initiating a signature campaign on the issues at hand on social media and has urged all doctors to join and collect hundreds of thousands of signatures to demand justice from the government.

admin is an online Health Portal. This platform provides valuable health information for managing health, better lifestyle & support to those who seek information on health issues. Our contents are timely and credible. is a growing web portal with many columnists & writers contributing from all over India.

1 Comment

  1. hello there and thank you for your information – I have definitely picked up something new from right here. I did however expertise several technical points using this web site, as I experienced to reload the web site lots of times previous to I could get it to load properly. I had been wondering if your web hosting is OK? Not that I am complaining, but slow loading instances times will very frequently affect your placement in google and could damage your quality score if advertising and marketing with Adwords. Well I’m adding this RSS to my email and can look out for much more of your respective fascinating content. Ensure that you update this again very soon..

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Previous Story

he Union Minister for Health & Family Welfare, Shri J.P. Nadda flagging off the Mass Awareness Slogan Walkathon, on the occasion of World No Tobacco Day 2017, in New Delhi on May 31, 2017. The Minister of State for Health & Family Welfare, Shri Faggan Singh Kulaste and the Director General Health Services, Dr. Jagdish Prasad are also seen.

Next Story

Amend the IMC Act to ensure professional autonomy, says IMA

Latest from Latest